American Fusion(TM) Inc. (AMFN) Adds Veteran Physicist as

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
69
American Fusion(TM) Inc. (AMFN) Adds Veteran Physicist as Advisor and Completes Texatron(TM) Fusion Engine(TM) Testing Framework


- Dr. Robert V. Duncan has been appointed an independent scientific and strategic advisor, adding critical expertise in national laboratories, research leadership, and technology commercialization.

- The company has also finalized a comprehensive testing protocol for the upcoming validation of its 5MW Pre-Production Texatron(TM) Fusion Engine(TM).

- The testing framework is designed to support independent scientific evaluation, with calibrated diagnostics, third-party observation and public reporting planned.

- American Fusion(TM) continues to expand its intellectual property portfolio, with additional patent applications covering elements of the Texatron(TM) platform, and recently presented its technology at IEEE ICOPS 2026, engaging with researchers and engineers in the plasma science community.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, has taken further steps in advancing its fusion energy development program, appointing an experienced physicist as an independent scientific advisor while completing the testing framework that will govern validation of its Texatron(TM) Fusion Engine(TM) platform.

The company announced that Dr. Robert V. Duncan has joined American Fusion(TM) as an Independent Scientific and Strategic Advisor. Dr. Duncan brings more than three decades of experience spanning physics research, national laboratories, university leadership and technology commercialization. He currently serves as President’s Distinguished Chair in Physics and Professor of Physics at Texas Tech University (https://nnw.fm/kWwPm ).

During his career, he has also held senior positions including Vice President for Research at Texas Tech University, Vice Chancellor for Research at the University of Missouri, Distinguished Member of Technical Staff at Sandia National Laboratories and Founding Director of the New Mexico Consortium at Los Alamos National Laboratory.

His experience extends beyond academic research. Dr. Duncan has served on the United States Air Force Scientific Advisory Board, participated on National Academy of Sciences panels and worked as a NASA Flight Principal Investigator. He is also a Fellow of both the American Physical Society and the National Academy of Inventors.

According to American Fusion(TM), his scientific background covers areas including superconductivity, cryogenic instrumentation, advanced materials, isotope physics, scientific diagnostics and fusion-related energy systems. Equally relevant from an investor perspective is his record in intellectual property development and technology commercialization. Dr. Duncan is named on numerous U.S. and international patent filings, several of which have supported commercial technology ventures.

Chief Technology Officer Dr. John Brandenburg said Dr. Duncan’s experience across government laboratories, advanced energy research, instrumentation and intellectual property development will provide independent scientific perspective as the company advances the Texatron(TM) Fusion Engine(TM) platform. Executive Chairman Brent Nelson added that the appointment reflects the company’s effort to strengthen its scientific and governance framework as development progresses.

The advisory appointment coincides with another milestone announced by the company. American Fusion(TM) said it has completed the comprehensive testing protocol that will guide validation of its 5MW Pre-Production Texatron(TM) Fusion Engine(TM), establishing a structured engineering framework intended to evaluate system performance, operating characteristics and safety (https://nnw.fm/0Hpv4).

Rather than relying on a single performance metric, the testing program incorporates multiple scientific measurements designed to characterize different aspects of plasma behavior and system operation.

Among the planned evaluations are plasma density measurements, plasma temperature monitoring, neutron detection, optical spectroscopy and detailed electrical power analysis. Together, these diagnostics are intended to generate engineering data describing plasma confinement, fusion conditions and overall system performance.

The company also said all diagnostic equipment will undergo documented calibration procedures before testing begins, with recognized standards used where applicable to improve data quality and repeatability.

Another element of the testing framework involves independent observation. American Fusion(TM) intends to invite qualified scientists, engineers and physicists to observe portions of the testing program and review engineering results. The company has also stated that future testing activities are expected to include publicly released video documentation together with independent third-party reports evaluating the results.

Fusion remains an emerging technology sector where many companies are pursuing different approaches to plasma confinement, fuel cycles and reactor design. American Fusion(TM) is developing an aneutronic fusion platform through its wholly owned subsidiary, Kepler Fusion Technologies. Unlike conventional fusion concepts that generate significant neutron flux, aneutronic approaches are intended to minimize neutron production, although neutron monitoring remains part of the company’s testing program to characterize operating conditions.

Alongside engineering development, the company continues expanding its intellectual property portfolio. Its most recent patent filing covers aspects of the Texatron(TM) Fusion Engine(TM) architecture, including a toroidal chamber design featuring a rifled interior geometry intended to receive pulsed electrical energy. Management said the filing forms part of a broader patent strategy spanning plasma confinement, diagnostics, power delivery, manufacturing methods and related technologies.

American Fusion(TM) also reported continued engagement with the scientific community following Dr. Brandenburg’s presentation at the IEEE International Conference on Plasma Science (“ICOPS”) 2026. Company representatives said discussions with researchers, engineers and physicists attending the conference provided technical feedback as development of the Texatron(TM) platform continues.

American Fusion(TM) is pursuing a modular approach through the Texatron(TM) Fusion Engine(TM), targeting future applications across industrial facilities, commercial infrastructure, defense systems and grid-constrained environments.

The company emphasized that current activities remain focused on engineering validation and commercial deployment. With its testing framework now established and scientific advisory capabilities strengthened, management said the next phase includes installation of the 5MW pre-production system, integration of diagnostic instrumentation, continued regulatory coordination and execution of the planned validation program.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://nnw.fm/AMFN

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer    

American Fusion Inc (AMFN) Stock Research Links

AMFN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 34

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 30

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 47

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 18

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 25

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Crest Surf Clubs Expands with Major Milestone Achievements

Updated Category News Views 150

Crest Surf Clubs Achieves Key Membership Milestone Crest Surf Clubs has reached a notable achievement, with more than 50% of memberships reserved at its flagship location before the official opening. This milestone showcases the growing demand for a unique surf club environment, emphasizing a strong interest in their exclusive surfing experience. Partnership with Wedbush...

Continue Reading
Exploring KBRA's Preliminary Ratings for PMT Loan Trust 2025-INV2

Updated Category News Views 303

Understanding KBRA's Ratings on PMT Loan Trust 2025-INV2 In a significant move, KBRA has assigned preliminary ratings to 62 classes of mortgage-backed notes from PMT Loan Trust 2025-INV2, also known as PMTLT 2025-INV2. This prime Residential Mortgage-Backed Securities (RMBS) transaction is initiated by PennyMac Corp., which is a wholly-owned subsidiary of PennyMac...

Continue Reading
ImmuCell Welcomes New Chief Financial Officer Timothy C. Fiori

Updated Category News Views 342

ImmuCell Strengthens Leadership with New CFO Appointment ImmuCell Corporation (Nasdaq: ICCC), a prominent player in the animal health sector dedicated to improving the well-being of dairy and beef cattle, has taken a significant step forward with the hiring of Timothy C. Fiori as Chief Financial Officer. This strategic recruitment is aimed at bolstering the company’s...

Continue Reading
Exploring the Promising Rise of Recombinant Hair Keratin Protein

Updated Category News Views 205

Overview of the Recombinant Human Hair Keratin Protein Market The recombinant human hair keratin protein market is witnessing a significant surge, propelled by a heightened awareness of hair health and advancements in biotechnology. As companies strive to innovate and meet growing consumer demands, the projected revenues in this sector are expected to reach well into the...

Continue Reading
Revolutionizing Logistics: ITF Group Teams Up with HaulerHub

Updated Category News Views 156

Transforming Logistics through Innovation ITF Group has forged an exciting partnership with HaulerHub to launch a platform that revolutionizes the connection between shippers and haulers. This innovative platform is designed to bring a thoroughly vetted and verified network of haulers to the forefront, addressing long-standing issues within the logistics industry....

Continue Reading